Impact Of Co-morbidities On Screening, Diagnosis, Treatment And Survival Of Cervical Cancer Amongst Australian Indigenous And Non-Indigenous Women: 1997-2009
Funder
National Health and Medical Research Council
Funding Amount
$98,236.00
Summary
Indigenous women are more likely than non-Indigenous Australian women to be diagnosed with cervical cancer and are less likely to survive it. This study will investigate the impact of co-exisiting chronic diseases (co-morbidities) on cervical cancer screening, diagnosis, treatment and survival outcomes for Indigenous compared to non-Indigenous women. Results from this study will assist in directing future public health initiatives that aim to improve outcomes for women with cervical cancer.
Reducing Disparities In Cervical Cancer Incidence For Aboriginal And Torres Strait Islander Women Through Screening And Vaccination
Funder
National Health and Medical Research Council
Funding Amount
$329,768.00
Summary
This program of research will aim to reduce cervical cancer incidence for Indigenous women by developing and trialling health systems interventions to increase cervical screening participation and HPV vaccination coverage. This research will be led by an Indigenous researcher with Indigenous people and for Indigenous people.
Cervical Screening Participation And Outcomes For Indigenous Australian Women
Funder
National Health and Medical Research Council
Funding Amount
$601,546.00
Summary
Cervical cancer is much more common among Indigenous than other Australian women, however little is known about their cervical screening participation or outcomes. This study will use Pap Test Registers and other data sources to compare screening participation and outcomes for Indigenous and non-Indigenous women, and investigate whether cervical cancer incidence has decreased for Indigenous women in recent years, as it has done for non-Indigenous women in Australia.